Peptide Synthesis Market: Top Companies, Insights and Trends

Market Trends

AI & ML Adoption • Enables faster drug discovery, peptide design, and toxicity prediction. • Supports automation and productivity in synthesis processes.

Green & Sustainable Manufacturing • Partnerships for solvent recovery and eco-friendly peptide production. • Example: Donaldson and PolyPeptide Group's solvent recovery system (May 2024).

Investments & Expansions • Amneal Pharmaceuticals to invest $200M over 5 years for peptide drug development. • Snapdragon Chemistry developing liquid-phase technology to reduce waste.

FDA Activity • 31 peptide drugs approved by the FDA between 2016 and 2023. • 9 TIDES (including peptides) approved in 2023 alone.

Key Market Insights

• North America held the largest share in 2024 due to R&D capabilities and leading market players. • Asia-Pacific is the fastest-growing region fueled by generic pharma, investments, and government support. • Reagents & Consumables are the top-selling products due to their necessity and repeat use. • Hybrid Technology and Equipment segments are the fastest-growing, driven by innovation and automation. • Therapeutics remains the largest application, especially in oncology and metabolic disorders.

Market Dynamics

Drivers

Growing R&D Activities • Expanding use in cancer, infectious, metabolic, and CNS disorders. • Peptides used in therapeutics, vaccines, diagnostics, and bioassays.

Technological Advancements • Solid-phase, liquid-phase, and hybrid peptide synthesis techniques improving output and purity.

Restraints

Sustainability Challenges • Use of hazardous solvents, difficult resin recycling.

High Purification Costs • Longer peptides require expensive processes to remove synthesis byproducts.

Opportunities

Recombinant Peptide Synthesis • Enables large-scale, high-yield, and purer peptide production. • Combines synthetic and biological processes to improve cost-efficiency and peptide stability.

Regional Insights

North America

• Dominant in 2024; home to key players like Thermo Fisher, GenScript, and Sigma Aldrich. • Strong R&D ecosystem with FDA approvals and government funding.

Asia-Pacific

• Fastest-growing due to India’s booming generic industry and China’s $37B in licensing deals in 2023. • Supportive government initiatives in R&D and pharma exports.

Europe

• Growth driven by biologics demand and strong R&D institutions. • Hosting European Peptide Synthesis Conference 2025 in Portugal.

Segment Highlights

By Product:

Reagents & Consumables (Dominant) • Essential for synthesis; includes amino acids, resins, coupling agents, etc.

Equipment (Fastest-Growing) • Tech innovations like peptide synthesizers and chromatography tools boost growth.

By Technology:

Liquid Phase Peptide Synthesis (LPPS) (Leader) • Cost-effective and environmentally friendly.

Hybrid Technology (Fastest-Growing) • Combines chemical and biological synthesis for better scalability and efficiency.

By Application:

Therapeutics (Dominant) • Peptides used in chronic disease treatments with FDA support.

Diagnosis (Fastest-Growing) • Peptides help detect biomarkers; used in imaging and non-invasive testing.

By End-Use:

Pharma & Biotech Companies (Leader) • In-house capabilities, infrastructure, and funding.

CDMO/CROs (Fastest-Growing) • Outsourcing increases efficiency, reduces time-to-market.

Top Companies